Dexilant 60 mg, Kapseln mit veränderter Wirkstofffreisetzung

7680629930037 CH-62993 Kapseln mit veränderter Wirkstofffreisetzung
Dexilant 60 mg, Kapseln mit veränderter Wirkstofffreisetzung
Dexilant 60 mg, Kapseln mit veränderter Wirkstofffreisetzung
Dexilant 60 mg, Kapseln mit veränderter Wirkstofffreisetzung
1 / 3
google

Article details

Package size
14
Selling units
14
Measure
Kapsel(n)
Galenic form
Kapseln mit veränderter Wirkstofffreisetzung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
03/03/2023
Summary of Product Characteristics
Français
03/03/2023
Patient information leaflet
Allemand
06/07/2021
Patient information leaflet
Français
06/07/2021
Patient information leaflet
Italien
06/07/2021

Detailed composition

Substance Quantity Type Category
(N/A)
60.0 MG Substance Wirkstoff (Principe actif)
sacchari sphaerae
- Substance HNIDK
saccharum
- Substance HNIDK
maydis amylum
- Substance HNIDK
magnesii subcarbonas ponderosus
- Substance HNIDK
saccharum
- Substance HNIDK
hydroxypropylcellulosum substitutum humile
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK
acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum
- Substance HNIDK
acidi methacrylici et methylis methacrylatis polymerisatum 1:2
- Substance HNIDK
acidi methacrylici et methylis methacrylatis polymerisatum 1:1
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
macrogolum 8000
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
triethylis citras
- Substance HNIDK
carrageenanum
- Substance HNIDK
(N/A)
- Substance FIMDK
kalii chloridum
- Substance HNIDK
E 171
- Substance FNIDK
E 132
- Substance FIMDK
aqua purificata
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 132
- Substance FIMDK
cera carnauba
- Substance HNIDK
lacca
- Substance HNIDK
glyceroli mono-oleas
- Substance HNIDK
natrium
0.02 MG Substance HBESI
saccharum
76.32 MG Substance HBESI

Reimbursement information

Public price
CHF 32.10
Specialties list
Yes
Generic
No
SL addition date: 01/07/2014

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
62993
Drug name
Dexilant, Kapseln mit veränderter Wirkstofffreisetzung
Galenic form
RETH
ATC Code
A02BC06
Authorization status
Z
Dispensing category
B
First authorization
09/05/2014
Authorization expiration date
31/12/9999
IT Number
04.99.0.
Domain
Human medicine
Field of application
Protonenpumpenhemmer

Package details

Description (FR)
DEXILANT caps ret 60 mg 14 pce
Description (DE)
DEXILANT Ret Kaps 60 mg 14 Stk
Market launch
09/05/2014
Narcotic (BTM)
No

Other package sizes (5)

DEXILANT caps ret 30 mg 14 pce
14 KAP
GTIN: 7680629930013
View
DEXILANT caps ret 30 mg 28 pce
28 KAP
GTIN: 7680629930020
View
DEXILANT caps ret 30 mg 98 pce
98 KAP
GTIN: 7680629930051
View
DEXILANT caps ret 60 mg 28 pce
28 KAP
GTIN: 7680629930044
View
DEXILANT caps ret 60 mg 56 pce
56 KAP
GTIN: 7680629930068
View